Your browser doesn't support javascript.
loading
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).
Reijneveld, Jaap C; Machingura, Abigirl; Coens, Corneel; Taphoorn, Martin J B; Taal, Walter; Clement, Paul M; Idbaih, Ahmed; de Vos, Filip Y F; Klein, Martin; Wick, Wolfgang; Mulholland, Paul J; Lewis, Joanne; Golfinopoulos, Vassilis; Ghislain, Irina; Bottomley, Andrew; van den Bent, Martin J.
Afiliação
  • Reijneveld JC; Department of Neurology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; SEIN, Heemstede, the Netherlands. Electronic address: jc.reijneveld@amsterdamumc.nl.
  • Machingura A; EORTC Headquarters,Brussels, Belgium.
  • Coens C; EORTC Headquarters,Brussels, Belgium.
  • Taphoorn MJB; Leiden University Medical Center, Leiden and Haaglanden Medical Center, The Hague, the Netherlands.
  • Taal W; Department of Neurology, Erasmus MC Cancer Institute, Dr. Molenwaterplein 40, PO Box 2040, 3015 GD, Rotterdam, the Netherlands.
  • Clement PM; Department of Oncology, Leuven Cancer Institute, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
  • Idbaih A; Sorbonne Université, AP-HP, Institut du Cerveau, Paris Brain Institute, ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière, Charles Foix, DMU Neurosciences, Servicede Neurologie 2-Mazarin, F-75013, Paris, France.
  • de Vos FYF; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Klein M; Amsterdam UMC Location Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081HV, Amsterdam, the Netherlands.
  • Wick W; Universitaets Klinikum Heidelberg, Head Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
  • Mulholland PJ; University College Hospital, 235 Euston Road, NW1 2BU, London,UK.
  • Lewis J; Newcastle Hospitals NHS Trust, Freeman Hospital, Northern Centre for Cancer Care, Freeman Road, High Heaton, NE7 7DN, Newcastle upon Tyne, UK.
  • Golfinopoulos V; EORTC Headquarters,Brussels, Belgium.
  • Ghislain I; EORTC Headquarters,Brussels, Belgium.
  • Bottomley A; EORTC Headquarters,Brussels, Belgium.
  • van den Bent MJ; Erasmus MC, Dr. Molenwaterplein 40, PO Box 2040, 3015 GD Rotterdam, the Netherlands.
Eur J Cancer ; 190: 112946, 2023 09.
Article em En | MEDLINE | ID: mdl-37453240
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article